Rare extreme polygenic risk scores strongly indicate Alzheimer's disease risk
- 1University of Kentucky
Abstract
BackgroundAlzheimers disease (AD) pathology often accumulates years before memory loss, creating a need to identify high-risk individuals presymptomatically. Polygenic risk scores (PRS) stratify AD risk, but individual-level predictions remain uncertain. Extreme PRS may identify high-risk individuals independent of APOE.
MethodsUsing GenoPred, extreme tails of 1,752 PRS methods were evaluated across four genetic ancestries using 11,200 autopsy- or clinically-defined AD cases and 19,321 controls (age [≥]65) from the AD Sequencing Project (ADSP) Release 5.
ResultsIndividuals in the extreme upper PRS tail were significantly enriched for AD in all ancestries: Admixed American (Padj=0.02727), African (Padj=0.004827), East Asian (Padj=0.02824), and European (Padj=2.3068x10-13). No controls were observed among the 42 European- and 12 African-ancestry individuals with extreme PRS. Extreme PRS spanned APOE diplotypes; 38% occurred in non-APOE {varepsilon}4 carriers.
ConclusionsRare subsets of individuals at the most extreme PRS thresholds have markedly elevated AD enrichment across ancestries and APOE diplotypes.
Data AvailabilityAll data are available through the ADSP, which is managed by The National Institute on Aging Genetics of Alzheimers Disease Data Storage Site (NIAGADS).
Related
- Incident versus prevalent progressive supranuclear palsy: analyses of U.S. Alzheimer's Disease Research Centers data indicate clinical and neuropathological features of a relatively common and underrecognized tauopathy in the aging brain.
- Pathway‐specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease
- Digital completion time relates more strongly to Alzheimer's disease-type atrophy than to vascular burden in a community cohort.
- Alzheimer's Polygenic Risk Scores Are Not Interchangeable: Evidence from 1,752 Models
- Utility of a coronary artery disease polygenic risk score in a low-risk primary prevention cohort
BibTeX
@misc{ward2026rare,
title = {{Rare extreme polygenic risk scores strongly indicate Alzheimer's disease risk}},
author = {E. L. Ward and P. T. Nelson and Y. Katsumata and D. W. Fardo and G. A. Jicha and Alzheimer's Disease Neuroimaging Initiative and J. B. Miller},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.08.26362504},
url = {https://www.medrxiv.org/content/10.64898/2026.09.08.26362504v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Rare extreme polygenic risk scores strongly indicate Alzheimer's disease risk
AU - E. L. Ward
AU - P. T. Nelson
AU - Y. Katsumata
AU - D. W. Fardo
AU - G. A. Jicha
AU - Alzheimer's Disease Neuroimaging Initiative
AU - J. B. Miller
PY - 2026
DA - 2026/09/08
PB - medRxiv
DO - 10.64898/2026.09.08.26362504
UR - https://www.medrxiv.org/content/10.64898/2026.09.08.26362504v1
AB - BackgroundAlzheimers disease (AD) pathology often accumulates years before memory loss, creating a need to identify high-risk individuals presymptomatically. Polygenic risk scores (PRS) stratify AD risk, but individual-level predictions remain uncertain. Extreme PRS may identify high-risk individuals independent of APOE. MethodsUsing GenoPred, extreme tails of 1,752 PRS methods were evaluated across four genetic ancestries using 11,200 autopsy- or clinically-defined AD cases and 19,321 controls (age [≥]65) from the AD Sequencing Project (ADSP) Release 5. ResultsIndividuals in the extreme upper PRS tail were significantly enriched for AD in all ancestries: Admixed American (Padj=0.02727), African (Padj=0.004827), East Asian (Padj=0.02824), and European (Padj=2.3068x10-13). No controls were observed among the 42 European- and 12 African-ancestry individuals with extreme PRS. Extreme PRS spanned APOE diplotypes; 38% occurred in non-APOE {varepsilon}4 carriers. ConclusionsRare subsets of individuals at the most extreme PRS thresholds have markedly elevated AD enrichment across ancestries and APOE diplotypes. Data AvailabilityAll data are available through the ADSP, which is managed by The National Institute on Aging Genetics of Alzheimers Disease Data Storage Site (NIAGADS).
ER -